Clinical outcome of gastric cancer patients with bone marrow metastases

Oncology

Volumn 73, Issue 3-4, 2008, Pages 192-197

  Kim, Hyo Song ^a   Yi, Seong Yoon ^a   Jun, Hyun Jung ^a   Lee, Jeeyun ^a   Park, Joon Oh ^a   Park, Young Suk ^a   Jang, Junho ^a   Kim, Hee Jin ^a   Ko, Younghyeh ^a   Lim, Ho Yeong ^a   Kang, Won Ki ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Bone marrow; Gastric cancer; Metastasis

Indexed keywords

ALKALINE PHOSPHATASE; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LACTATE DEHYDROGENASE; OXALIPLATIN; PACLITAXEL;

ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW METASTASIS; CANCER SURVIVAL; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SIGNET RING CARCINOMA; STOMACH CANCER; SYMPTOM; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BONE MARROW NEOPLASMS; BONE NEOPLASMS; CARCINOMA, SIGNET RING CELL; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 43049088853     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000127386     Document Type: Article

References (20)

1. Kelley JR, Duggan JM: Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003;56:1-9.
2. Shin HR, Jung KW, Won YJ, Park JG, 139 KCCR-affiliated Hospitals: 2002 annual report of the Korea central cancer registry: based on registered data from 139 hospitals. Cancer Res Treat 2004;36:103-114.
3. Anner RM, Drewinko B: Frequency and significance of bone marrow involvement by metastatic solid tumors. Cancer 1977;39:1337-1344.
4. Johnston AD: Pathology of metastatic tumors in bone. Clin Orthop Relat Res 1970;73:8-32.
5. Miric A, Banks M, Allen D, Feighan J, Petersilge CA, Carter JR, Makley JT: Cortical metastatic lesions of the appendicular skeleton from tumors of known primary origin. J Surg Oncol 1998;67:255-260.
6. Hayes DF: Prognostic and predictive factors revisited. Breast 2005;14:493-499.
7. Kobayashi M, Okabayashi T, Sano T, Araki K: Metastatic bone cancer as a recurrence of early gastric cancer - characteristics and possible mechanisms. World J Gastroenterol 2005;11:5587-5591.
8. Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, Naume B: Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 2003;21:3469-3478.
9. Kusumoto H, Haraguchi M, Nozuka Y, Oda Y, Tsuneyoshi M, Iguchi H: Characteristic features of disseminated carcinomatosis of the bone marrow due to gastric cancer: the pathogenesis of bone destruction. Oncol Rep 2006;16:735-740.
10. Tokar M, Bobilev D, Ariad S, Geffen DB: Disseminated intravascular coagulation at presentation of advanced gastric cancer. Isr Med Assoc J 2006;8:853-855.
11. Lee J, Lim T, Uhm J, Park K, Park S, Lee S, Park J, Park Y, Lim H, Sohn T, Noh J, Heo J, Park C, Kim S, Kang W: Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma. Ann Oncol 2007;18:886-891.
12. Chau I, Norman AR, Cunningham D, Waters JS, Oates J, Ross PJ: Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer - pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 2004;22:2395-2403.
13. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, Francois Y, Vignal J, Gilly FN: Peritoneal carcinomatosis from non-gynecologic malignancies: results of the evocape 1 multicentric prospective study. Cancer 2000;88:358-363.
14. Kim JG, Ryoo BY, Park YH, Kim BS, Kim TY, Im YH, Kang YK: Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy. Cancer Chemother Pharmacol 2008;61:301-307.
15. Batson OV: The function of the vertebral veins and their role in the spread of metastases. 1940. Clin Orthop Relat Res 1995:4-9.
16. Campling B, Quirt I, DeBoer G, Feld R, Shepherd FA, Evans WK: Is bone marrow examination in small-cell lung cancer really necessary? Ann Intern Med 1986;105:508-512.
17. Bezwoda WR, Lewis D, Livini N: Bone marrow involvement in anaplastic small cell lung cancer. Diagnosis, hematologic features, and prognostic implications. Cancer 1986;58:1762-1765.
18. Jonsson U, Rundles RW: Tumor metastases in bone marrow. Blood 1951;6:16-25.
19. Tritz DB, Doll DC, Ringenberg QS, Anderson S, Madsen R, Perry MC, Yarbro JW: Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables. Cancer 1989;63:763-766.
20. Chernow B, Wallner SF: Variables predictive of bone marrow metastasis. Cancer 1978;42:2373-2378.